Jun. 21, 2022 16:16

Companies in the Global Omics Based Clinical Trials Market Expedite Product Innovations to Stay at Forefront; Expected Sales to Reach USD 61.7 Bn By 2032: Fact.MR’s Study

The Omics Based Clinical Trials Market revenues were estimated at USD 26.2 Bn in 2021 and is anticipated to grow at a CAGR of 8.1% from 2022 to 2032, according to a recently published Fact.MR report. By the end of 2032, the market is expected to r...

Jun. 21, 2022 15:55

NAVER Cloud hosts Korea’s first Sovereign Cloud-based HSM Service powered by Thales

Thales today announced it is helping NAVER Cloud launch the first Korean sovereign cloud HSM as-a-service powered by Thales' industry-leading Luna Network Hardware Security Module. The new service helps businesses meet the strict regulatory and in...

Jun. 21, 2022 15:45

AOP Health Presents Final Results From Its CONTINUATION-PV Study - up to 7.5 Years Treatment With BESREMi® (Ropeginterferon alfa-2b) of Polycythaemia Vera Patients - at EHA 2022 Annual Meeting

AOP Health announced the final results on Ropeginterferon alfa-2b in patients with Polycythaemia Vera (PV) from its CONTINUATION-PV study in an oral presentation at the prestigious EHA (European Hematology Association) 2022 Annual Meeting by Profe...

Jun. 21, 2022 11:55

Cirium Moves Towards Becoming the Standard for Airline CO2 Emissions Reporting

Cirium, the aviation analytics company, has developed an advanced methodology to provide a standard and accurate picture of CO2 emissions and fuel burn calculations per flight and aircraft seat. Jeremy Bowen, CEO at Cirium said: “The level of prec...

Jun. 21, 2022 09:45

Quectel Launches High Performance Single-Band GNSS Positioning Module LC76G With Ultra-low Power Consumption

Quectel Wireless Solutions, a global IoT solutions provider, today announced the release of its LC76G module, a single-band compact GNSS module featuring fast and accurate location performance as well as ultra-low power consumption. The LC76G has ...

Jun. 20, 2022 16:30

Solasia Pharma: DARVIAS® Injection 135mg (Generic Name: DARINAPARSIN /Development Code: SP-02) Approved in Japan

Solasia Pharma K.K. (TSE: 4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter “Solasia”) officially announced today that an organoarsenic drug “DARVIAS® Injection 135mg” (SP-02, hereinafter DARVIAS®) has been approved fo...

Jun. 20, 2022 14:30

Increasing Prevalence of Diabetic Ketoacidosis Is Expected to Drive Growth of Blood Ketone Meter Market: Fact.MR’s Study

The Blood Ketone Meter market revenues were estimated at US$ 275 Mn in 2021 and are anticipated to grow at a CAGR of 8.1% from 2022-2032 according to a recently published Fact.MR report. By the end of 2032, the market is expected to reach US$ 646 ...

Jun. 20, 2022 10:30

2022 Safety and Security Summit @ Esri UC to Showcase Building Resilient Communities

Esri, the global leader in location intelligence, today announced the detailed agenda of the 2022 Safety and Security Summit @ Esri UC, the world's largest GIS event dedicated to public safety, emergency management, and national security. Formerly...

Jun. 20, 2022 09:45

PJSC Magnitogorsk Iron and Steel Works: MMKnotifies on second extention of consent solicitation process

PJSC Magnitogorsk Iron & Steel Works (MOEX: MAGN; LSE: MMK) notifies on the second extension of the Consent Solicitation for its outstanding U.S.$500,000,000 4.375 per cent. Guaranteed Notes due 2024. On 9 June 2022, PJSC Magnitogorsk Iron & Steel...

Jun. 17, 2022 17:40

IFPMA: Pharmaceutical Industry Expresses Deep Disappointment With Decision on Waiving Intellectual Property Rights Adopted at the World Trade Organization Ministerial Conference

Today’s decision at the World Trade Organization (WTO) Ministerial Conference (MC12) to endorse a TRIPS waiver for COVID-19 vaccines sends the wrong message to those carrying out research and development and innovating. It incorrectly points to in...